Tumor necrosis factor-α mediates JNK activation response to intestinal ischemia-reperfusion injury

World Journal of Gastroenterology

Volumn 19, Issue 30, 2013, Pages 4925-4934

  Yang, Qi ^a   Zheng, Feng Ping ^a   Zhan, Ya Shi ^a   Tao, Jin ^a   Tan, Si Wei ^a   Liu, Hui Ling ^a   Wu, Bin ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Apoptosis; C Jun N terminal kinase; Intestine; Mucosa; Tumor necrosis factor

Indexed keywords

CASPASE 3; CASPASE 9; INFLIXIMAB; PENTOXIFYLLINE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INTESTINE INJURY; INTESTINE ISCHEMIA; MALE; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; SCORING SYSTEM; SIGNAL TRANSDUCTION; SUPERIOR MESENTERIC ARTERY OBSTRUCTION; WESTERN BLOTTING;

EID: 84881493967     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i30.4925     Document Type: Article

References (33)

1. Mallick IH, Yang W, Winslet MC, Seifalian AM. Ischemiareperfusion injury of the intestine and protective strategies against injury. Dig Dis Sci 2004; 49: 1359-1377 [PMID: 15481305]
2. Esposito E, Cuzzocrea S. TNF-alpha as a therapeutic target in inflammatory diseases, ischemia-reperfusion injury and trauma. Curr Med Chem 2009; 16: 3152-3167 [PMID: 19689289 DOI: 10.2174/092986709788803024]
3. Kostopanagiotou G, Avgerinos ED, Markidou E, Voiniadis P, Chondros C, Theodoraki K, Smyrniotis V, Arkadopoulos N. Protective effect of NAC preconditioning against ischemia-reperfusion injury in piglet small bowel transplantation: effects on plasma TNF, IL-8, hyaluronic acid, and NO. J Surg Res 2011; 168: 301-305 [PMID: 20036383 DOI: 10.1016/ j. jss.2009.09.002]
4. Deng Y, Ren X, Yang L, Lin Y, Wu X. A JNK-dependent pathway is required for TNFalpha-induced apoptosis. Cell 2003; 115: 61-70 [PMID: 14532003 DOI: 10.1016/ S0092-8674(03)00757-8]
5. Ikeda H, Suzuki Y, Suzuki M, Koike M, Tamura J, Tong J, Nomura M, Itoh G. Apoptosis is a major mode of cell death caused by ischaemia and ischaemia/reperfusion injury to the rat intestinal epithelium. Gut 1998; 42: 530-537 [PMID: 9616316 DOI: 10.1136/gut.42.4.530]
6. Noda T, Iwakiri R, Fujimoto K, Matsuo S, Aw TY. Programmed cell death induced by ischemia-reperfusion in rat intestinal mucosa. Am J Physiol 1998; 274: G270-G276 [PMID: 9486179]
7. Pergel A, Kanter M, Yucel AF, Aydin I, Erboga M, Guzel A. Anti-inflammatory and antioxidant effects of infliximab in a rat model of intestinal ischemia/reperfusion injury. Toxicol Ind Health 2012; 28: 923-932 [PMID: 22082824 DOI: 10.1177/ 0748233711427056]
8. Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg 1970; 101: 478-483 [PMID: 5457245 DOI: 10.1001/archsurg. 1970.01340280030009]
9. Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ 2003; 10: 45-65 [PMID: 12655295 DOI: 10.1038/sj. cdd.4401189]
10. Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 2003; 3: 745-756 [PMID: 12949498 DOI: 10.1038/nri1184]
11. Chen XL, Zhang Q, Zhao R, Ding X, Tummala PE, Medford RM. Rac1 and superoxide are required for the expression of cell adhesion molecules induced by tumor necrosis factoralpha in endothelial cells. J Pharmacol Exp Ther 2003; 305: 573-580 [PMID: 12606638 DOI: 10.1124/jpet.102.047894]
12. Esposito E, Mazzon E, Muià C, Meli R, Sessa E, Cuzzocrea S. Splanchnic ischemia and reperfusion injury is reduced by genetic or pharmacological inhibition of TNF-alpha. J Leukoc Biol 2007; 81: 1032-1043 [PMID: 17210619 DOI: 10.1189/ jlb.0706480]
13. Zhang C, Xu X, Potter BJ, Wang W, Kuo L, Michael L, Bagby GJ, Chilian WM. TNF-alpha contributes to endothelial dysfunction in ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol 2006; 26: 475-480 [PMID: 16385082 DOI: 10.1161/01. ATV.0000201932.32678.7e]
14. Souza DG, Teixeira MM. The balance between the production of tumor necrosis factor-alpha and interleukin-10 determines tissue injury and lethality during intestinal ischemia and reperfusion. Mem Inst Oswaldo Cruz 2005; 100 Suppl 1: 59-66 [PMID: 15962100 DOI: 10.1590/ S0074-02762005000900011]
15. Teoh N, Field J, Sutton J, Farrell G. Dual role of tumor necrosis factor-alpha in hepatic ischemia-reperfusion injury: studies in tumor necrosis factor-alpha gene knockout mice. Hepatology 2004; 39: 412-421 [PMID: 14767994 DOI: 10.1002/ hep.20035]
16. Teoh N, Leclercq I, Pena AD, Farrell G. Low-dose TNFalpha protects against hepatic ischemia-reperfusion injury in mice: implications for preconditioning. Hepatology 2003; 37: 118-128 [PMID: 12500196 DOI: 10.1053/jhep.2003.50009]
17. Helewski KJ, Kowalczyk-Ziomek GI, Czecior E, Swietochowska E, Wielkoszynski T, Czuba ZP, Szliszka E, Krol W. Administration of low doses of tumor necrosis factoralpha protects rat liver from ischaemic damage and reperfusion injury. J Physiol Pharmacol 2010; 61: 273-278 [PMID: 20610856]
18. Rüdiger HA, Clavien PA. Tumor necrosis factor alpha, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver. Gastroenterology 2002; 122: 202-210 [PMID: 11781294 DOI: 10.1053/gast.2002.30304]
19. Wu B, Fujise T, Iwakiri R, Ootani A, Amemori S, Tsunada S, Toda S, Fujimoto K. Venous congestion induces mucosal apoptosis via tumor necrosis factor-alpha-mediated cell death in the rat small intestine. J Gastroenterol 2004; 39: 1056-1062 [PMID: 15580398 DOI: 10.1007/s00535-004-1444-4]
20. Dérijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M, Davis RJ. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994; 76: 1025-1037 [PMID: 8137421 DOI: 10.1016/0092-8674(94)90380-8]
21. Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF, Avruch J, Woodgett JR. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 1994; 369: 156-160 [PMID: 8177321 DOI: 10.1038/369156a0]
22. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998; 281: 1305-1308 [PMID: 9721089 DOI: 10.1126/science.281.5381.1305]
23. Reinhard C, Shamoon B, Shyamala V, Williams LT. Tumor necrosis factor alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2. EMBO J 1997; 16: 1080-1092 [PMID: 9118946 DOI: 10.1093/emboj/16.5.1080]
24. King LA, Toledo AH, Rivera-Chavez FA, Toledo-Pereyra LH. Role of p38 and JNK in liver ischemia and reperfusion. J Hepatobiliary Pancreat Surg 2009; 16: 763-770 [PMID: 19680593 DOI: 10.1007/s00534-009-0155-x]
25. Won M, Park KA, Byun HS, Sohn KC, Kim YR, Jeon J, Hong JH, Park J, Seok JH, Kim JM, Yoon WH, Jang IS, Shen HM, Liu ZG, Hur GM. Novel anti-apoptotic mechanism of A20 through targeting ASK1 to suppress TNF-induced JNK activation. Cell Death Differ 2010; 17: 1830-1841 [PMID: 20448643 DOI: 10.1038/cdd.2010.47]
26. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature 2001; 410: 37-40 [PMID: 11242034 DOI: 10.1038/35065000]
27. Dhanasekaran DN, Reddy EP. JNK signaling in apoptosis. Oncogene 2008; 27: 6245-6251 [PMID: 18931691 DOI: 10.1038/onc.2008.301]
28. Deree J, Martins JO, Melbostad H, Loomis WH, Coimbra R. Insights into the regulation of TNF-alpha production in human mononuclear cells: the effects of non-specific phosphodiesterase inhibition. Clinics (Sao Paulo) 2008; 63: 321-328 [PMID: 18568240 DOI: 10.1590/S1807-59322008000300006]
29. Marqui CE, Silva HC, Ferez D, Cavassani SS, Moraes JB, Silva DA, Simões RS, Lopes CA, Taha MO, Oliveira-Júnior IS. Pretreatment with pentoxifylline attenuates lung injury induced by intestinal ischemia/reperfusion in rats. Acta Cir Bras 2011; 26: 438-444 [PMID: 22042105 DOI: 10.1590/ S0102-86502011000600006]
30. Cámara-Lemarroy CR, Guzmán-de la Garza FJ, Alarcón-Galván G, Cordero-Pérez P, Muñoz-Espinosa LE, Fernández-Garza NE. Effects of thalidomide and pentoxyphylline over local and remote organ injury after intestinal ischemia/ reperfusion. Transplant Proc 2010; 42: 1624-1626 [PMID: 20620488 DOI: 10.1016/j. transproceed.2009.12.074]
31. Di Sabatino A, Ciccocioppo R, Benazzato L, Sturniolo GC, Corazza GR. Infliximab downregulates basic fibroblast growth factor and vascular endothelial growth factor in Crohn's disease patients. Aliment Pharmacol Ther 2004; 19: 1019-1024 [PMID: 15113369 DOI: 10.1111/j.1365-2036.2004.01927. x]
32. Choy EH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001; 344: 907-916 [PMID: 11259725 DOI: 10.1056/NEJM200103223441207]
33. Guven C, Borcek AO, Cemil B, Kurt G, Yildirim Z, Ucankus NL, Kilic N, Ceviker N. Neuroprotective effects of infliximab in experimental spinal cord ischemic injury. J Clin Neurosci 2010; 17: 1563-1567 [PMID: 20817464 DOI: 10.1016/ j. jocn.2010.04.027]